135 related articles for article (PubMed ID: 24639341)
1. MRI artefacts after Bonebridge implantation.
Steinmetz C; Mader I; Arndt S; Aschendorff A; Laszig R; Hassepass F
Eur Arch Otorhinolaryngol; 2014 Jul; 271(7):2079-82. PubMed ID: 24639341
[TBL] [Abstract][Full Text] [Related]
2. The Bonebridge Bone Conduction Hearing Implant: indication criteria, surgery and a systematic review of the literature.
Sprinzl GM; Wolf-Magele A
Clin Otolaryngol; 2016 Apr; 41(2):131-43. PubMed ID: 26073720
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal economic analysis of Bonebridge 601 versus percutaneous bone-anchored hearing devices over a 5-year follow-up period.
Amin N; Soulby AJ; Borsetto D; Pai I
Clin Otolaryngol; 2021 Jan; 46(1):263-272. PubMed ID: 33068331
[TBL] [Abstract][Full Text] [Related]
4. The Bonebridge: preclinical evaluation of a new transcutaneously-activated bone anchored hearing device.
Huber AM; Sim JH; Xie YZ; Chatzimichalis M; Ullrich O; Röösli C
Hear Res; 2013 Jul; 301():93-9. PubMed ID: 23467173
[TBL] [Abstract][Full Text] [Related]
5. Safety and effectiveness of the Bonebridge transcutaneous active direct-drive bone-conduction hearing implant at 1-year device use.
Schmerber S; Deguine O; Marx M; Van de Heyning P; Sterkers O; Mosnier I; Garin P; Godey B; Vincent C; Venail F; Mondain M; Deveze A; Lavieille JP; Karkas A
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1835-1851. PubMed ID: 27475796
[TBL] [Abstract][Full Text] [Related]
6. Comparison of artefact reduction possibilities with the new active transcutaneous bone conduction implant (Bonebridge).
Edlinger S; Tenner E; Frühwald J; Sprinzl G
J Laryngol Otol; 2023 Mar; 137(3):263-269. PubMed ID: 35144697
[TBL] [Abstract][Full Text] [Related]
7. Improvement of speech perception in quiet and in noise without decreasing localization abilities with the bone conduction device Bonebridge.
Weiss R; Leinung M; Baumann U; Weißgerber T; Rader T; Stöver T
Eur Arch Otorhinolaryngol; 2017 May; 274(5):2107-2115. PubMed ID: 28032241
[TBL] [Abstract][Full Text] [Related]
8. Active Bone Conduction Prosthesis: Bonebridge(TM).
Zernotti ME; Sarasty AB
Int Arch Otorhinolaryngol; 2015 Oct; 19(4):343-8. PubMed ID: 26491482
[TBL] [Abstract][Full Text] [Related]
9. Transcutaneous bone-conduction hearing device: audiological and surgical aspects in a first series of patients with mixed hearing loss.
Barbara M; Perotti M; Gioia B; Volpini L; Monini S
Acta Otolaryngol; 2013 Oct; 133(10):1058-64. PubMed ID: 23768011
[TBL] [Abstract][Full Text] [Related]
10. The middle fossa approach with self-drilling screws: a novel technique for BONEBRIDGE implantation.
You P; Siegel LH; Kassam Z; Hebb M; Parnes L; Ladak HM; Agrawal SK
J Otolaryngol Head Neck Surg; 2019 Jul; 48(1):35. PubMed ID: 31358057
[TBL] [Abstract][Full Text] [Related]
11. Audiometric Comparison Between the First Patients With the Transcutaneous Bone Conduction Implant and Matched Percutaneous Bone Anchored Hearing Device Users.
Rigato C; Reinfeldt S; Håkansson B; Jansson KJ; Hol MK; Eeg-Olofsson M
Otol Neurotol; 2016 Oct; 37(9):1381-7. PubMed ID: 27631828
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Audiological Results Between a Transcutaneous and a Percutaneous Bone Conduction Instrument in Conductive Hearing Loss.
Gerdes T; Salcher RB; Schwab B; Lenarz T; Maier H
Otol Neurotol; 2016 Jul; 37(6):685-91. PubMed ID: 27093021
[TBL] [Abstract][Full Text] [Related]
13. BoneBridge implantation in patients with single-sided deafness resulting from vestibular schwannoma resection: objective and subjective benefit evaluations.
Yang J; Wang Z; Huang M; Chai Y; Jia H; Wu Y; Dai Y; Li Y; Wu H
Acta Otolaryngol; 2018 Oct; 138(10):877-885. PubMed ID: 30676881
[TBL] [Abstract][Full Text] [Related]
14. Hearing outcomes of the active bone conduction system Bonebridge
Carnevale C; Til-Pérez G; Arancibia-Tagle DJ; Tomás-Barberán MD; Sarría-Echegaray PL
Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(2):80-88. PubMed ID: 29784242
[TBL] [Abstract][Full Text] [Related]
15. Indication criteria and outcomes with the Bonebridge transcutaneous bone-conduction implant.
Riss D; Arnoldner C; Baumgartner WD; Blineder M; Flak S; Bachner A; Gstoettner W; Hamzavi JS
Laryngoscope; 2014 Dec; 124(12):2802-6. PubMed ID: 25142577
[TBL] [Abstract][Full Text] [Related]
16. A novel bone conduction implant (BCI): engineering aspects and pre-clinical studies.
Håkansson B; Reinfeldt S; Eeg-Olofsson M; Ostli P; Taghavi H; Adler J; Gabrielsson J; Stenfelt S; Granström G
Int J Audiol; 2010 Mar; 49(3):203-15. PubMed ID: 20105095
[TBL] [Abstract][Full Text] [Related]
17. Influence of head orientation and implantation site of a novel transcutaneous bone conduction implant on MRI metal artifact reduction sequence.
Talon E; Wimmer W; Hakim A; Kiefer C; Pastore-Wapp M; Anschuetz L; Mantokoudis G; Caversaccio MD; Wagner F
Eur Arch Otorhinolaryngol; 2022 Oct; 279(10):4793-4799. PubMed ID: 35072767
[TBL] [Abstract][Full Text] [Related]
18. Audiologic, surgical and subjective outcomes of active transcutaneous bone conduction implant system (Bonebridge).
Oh SJ; Goh EK; Choi SW; Lee S; Lee HM; Lee IW; Kong SK
Int J Audiol; 2019 Dec; 58(12):956-963. PubMed ID: 31460815
[No Abstract] [Full Text] [Related]
19. Magnetic Resonance Imaging Artifact Associated With Transcutaneous Bone Conduction Implants: Cholesteatoma and Vestibular Schwannoma Surveillance.
Nassiri AM; Messina SA; Benson JC; Lane JI; McGee KP; Trzasko JD; Carlson ML
Otolaryngol Head Neck Surg; 2024 Jan; 170(1):187-194. PubMed ID: 37582349
[TBL] [Abstract][Full Text] [Related]
20. Retrosigmoid implantation of an active bone conduction stimulator in a patient with chronic otitis media.
Lassaletta L; Sanchez-Cuadrado I; Muñoz E; Gavilan J
Auris Nasus Larynx; 2014 Feb; 41(1):84-7. PubMed ID: 23722197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
